NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets

Area of Science:

• Immunology
• Hematology
• Molecular Biology

Background:

• Toll-like receptors (TLRs) mediate immune responses via MyD88-dependent NF-κB activation.
• Anucleate platelets possess NF-κB machinery, but its function remains unclear.
• Platelets participate in innate immunity through pattern-recognition receptors like TLR2 and PAR1.

Purpose of the Study:

• To investigate the role of NF-κB in cytokine and serotonin release from human platelets.
• To compare NF-κB activation kinetics following TLR2 and PAR1 stimulation.
• To elucidate the contribution of NF-κB to platelet immune functions.

Main Methods:

• Stimulation of human platelets with TLR2 ligand (Pam3CSK4) and PAR1 agonist.
• Assessment of NF-κB and MAPK/AKT phosphorylation.
• Measurement of platelet-derived sCD62P, RANTES, sCD40L, and serotonin release.
• Inhibition of NF-κB using Bay11-7082.

Main Results:

• PAR1 activation rapidly induced NF-κB phosphorylation, while TLR2 activation showed a slower response.
• Both TLR2 and PAR1 activation induced similar ERK1/2, p38, and AKT phosphorylation.
• TLR2 activation increased sCD62P, RANTES, and sCD40L release, but not serotonin.
• NF-κB inhibition abolished TLR2/PAR1-induced release of sCD62P, RANTES, sCD40L, and partially inhibited PAR1-induced serotonin release.

Conclusions:

• NF-κB is a key regulator of platelet-mediated immune responses.
• Platelet activation via TLR2 and PAR1 differentially modulates NF-κB signaling.
• NF-κB plays a significant role in platelet cytokine and serotonin secretion, contributing to platelet immunomodulation.